Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23644118)

1.

[Expression of myeloid-derived suppressor cells in the peripheral blood and its clinical significance in renal carcinoma].

Feng S, Liu C, Zheng S, Huang P, Chen B, Guo K.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Apr;33(4):550-3. Chinese.

2.

[The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].

Xia R, Wang F, Gao T, Wen W, Lu B, Zhu Y, Zhang X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jul;30(7):740-3. Chinese.

PMID:
25001941
3.

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H, Zhao K.

PLoS One. 2013;8(2):e57114. doi: 10.1371/journal.pone.0057114. Epub 2013 Feb 20.

4.

A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.

Vetsika EK, Koinis F, Gioulbasani M, Aggouraki D, Koutoulaki A, Skalidaki E, Mavroudis D, Georgoulias V, Kotsakis A.

J Immunol Res. 2014;2014:659294. doi: 10.1155/2014/659294. Epub 2014 Nov 11.

5.

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.

Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, Guo HF, Miao ZN.

World J Gastroenterol. 2012 Jul 7;18(25):3303-9. doi: 10.3748/wjg.v18.i25.3303.

6.
7.

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer.

Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, Loeb M, Bramson JL, Bowdish DM.

J Leukoc Biol. 2013 Apr;93(4):633-7. doi: 10.1189/jlb.0912461. Epub 2013 Jan 22.

8.

[Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].

Cheng Y, Li H, Zhao D, Han Q, Liu Y, Liu X, Ma L, Liu J.

Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):592-6. Chinese.

PMID:
25430025
9.

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.

Jordan KR, Amaria RN, Ramirez O, Callihan EB, Gao D, Borakove M, Manthey E, Borges VF, McCarter MD.

Cancer Immunol Immunother. 2013 Nov;62(11):1711-22. doi: 10.1007/s00262-013-1475-x. Epub 2013 Sep 27.

10.

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Görgün GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, Raje N, Munshi NC, Richardson PG, Anderson KC.

Blood. 2013 Apr 11;121(15):2975-87. doi: 10.1182/blood-2012-08-448548. Epub 2013 Jan 15.

11.

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.

Höchst B, Schildberg FA, Sauerborn P, Gäbel YA, Gevensleben H, Goltz D, Heukamp LC, Türler A, Ballmaier M, Gieseke F, Müller I, Kalff J, Kurts C, Knolle PA, Diehl L.

J Hepatol. 2013 Sep;59(3):528-35. doi: 10.1016/j.jhep.2013.04.033. Epub 2013 May 9.

PMID:
23665041
12.
13.

Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.

Arihara F, Mizukoshi E, Kitahara M, Takata Y, Arai K, Yamashita T, Nakamoto Y, Kaneko S.

Cancer Immunol Immunother. 2013 Aug;62(8):1421-30. doi: 10.1007/s00262-013-1447-1. Epub 2013 Jun 14.

PMID:
23764929
14.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F.

Gastroenterology. 2008 Jul;135(1):234-43. doi: 10.1053/j.gastro.2008.03.020. Epub 2008 Mar 21. Erratum in: Gastroenterology. 2011 Aug;141(2):779.

PMID:
18485901
15.

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, Whiteside TL.

J Immunol Methods. 2012 Jul 31;381(1-2):14-22. doi: 10.1016/j.jim.2012.04.004. Epub 2012 Apr 13.

16.

Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.

Tian T, Gu X, Zhang B, Liu Y, Yuan C, Shao L, Guo Y, Fan K.

Cancer Biomark. 2015 Mar 19. [Epub ahead of print]

PMID:
25792471
18.

[Immunologic characteristics and prognosis of acute myeloid leukemia M1].

Zhao F, Chen Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):687-91. Chinese.

PMID:
17708783
19.

Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion.

Luan Y, Mosheir E, Menon MC, Wilson D, Woytovich C, Ochando J, Murphy B.

Am J Transplant. 2013 Dec;13(12):3123-31. doi: 10.1111/ajt.12461. Epub 2013 Sep 18.

20.

Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.

Brusa D, Simone M, Gontero P, Spadi R, Racca P, Micari J, Degiuli M, Carletto S, Tizzani A, Matera L.

Int J Urol. 2013 Oct;20(10):971-8. doi: 10.1111/iju.12086. Epub 2013 Feb 20.

PMID:
23421558
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk